Clinical Trials Directory

Trials / Completed

CompletedNCT05205655

Detection Dogs as a Help in the Detection of COVID-19

Canine Olfactory Detection and Its Relevance for the Medical Identification of Patients With COVID-19

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Hôpital Universitaire Sahloul · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Canine olfactive detection has proven its efficacy in numerous situations (explosives, drugs, bank notes…) including for early diagnosis of human diseases: various cancers, alert of diabetic or epileptic people in immediate alarm of crisis.

Detailed description

Fighting such a viral outbreak requires a widespread testing, one of the key measures for tackling the pandemic. In June 2020, facing a decline of COVID-19, it is possible to say that countries that have mastered their outbreak, and were able to maintain the number of infected people low, need to perform fewer test to correctly monitor the outbreak, than those countries where the virus has spread more widely. And for the same reasons, the timing of testing is also crucial. A high rate of testing will be way more effective to slow an outbreak if conducted earlier on, at a time when there is fewer infectious The aim of this study is to evaluate if the sweat produced by COVID-19 persons (SARS-CoV-2 PCR positive) has a different odour for trained detection dogs than the sweat produced by non COVID-19 persons. The study was conducted on 3 sites, following the same protocol procedures, and involved a total of 18 dogs. A total of 198 armpits sweat samples were obtained from different hospitals. For each involved dog, the acquisition of the specific odour of COVID-19 sweat samples required from one to four hours, with an amount of positive samples sniffing ranging from four to ten.

Conditions

Interventions

TypeNameDescription
BEHAVIORALcollection of odour samplesOdours will be collected by participants by putting sterile compresses under the armpits for at least 4 h.

Timeline

Start date
2021-03-01
Primary completion
2021-08-31
Completion
2021-08-31
First posted
2022-01-25
Last updated
2023-04-10

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT05205655. Inclusion in this directory is not an endorsement.